Helus Pharma Inc. (NASDAQ: HELP) Stock Competitors & Peer Comparison
See HELP's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for HELP and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HELP | $10.50 | -4.81% | 650.8M | -2.52 | -$4.16 | N/A |
| RPRX | $56.57 | -2.09% | 25.1B | 10.78 | $5.25 | +1.60% |
| CORT | $117.80 | -2.80% | 12.7B | 336.57 | $0.35 | N/A |
| WBA | $11.98 | +0.50% | 10.4B | -1.64 | -$7.29 | +4.17% |
| KNSA | $78.53 | -0.90% | 6B | 80.96 | $0.97 | N/A |
| LQDA | $26.81 | -3.11% | 2.4B | 19.57 | $1.37 | N/A |
| PBH | $48.53 | -0.97% | 2.3B | 10.98 | $4.42 | N/A |
| HROWL | $25.61 | +0.19% | 1.4B | N/A | N/A | N/A |
| HROWM | $26.03 | -0.08% | 1.3B | N/A | N/A | N/A |
| LTGO | $15.71 | -1.94% | 945M | -6.23 | -$2.52 | N/A |
Stock Comparison
Royalty Pharma plc (NASDAQ: RPRX)
HELP vs RPRX Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, RPRX has a market cap of 25.1B. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while RPRX trades at $56.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas RPRX's P/E ratio is 10.78. In terms of profitability, HELP's ROE is -0.71%, compared to RPRX's ROE of +0.12%. Regarding short-term risk, HELP is more volatile compared to RPRX. This indicates higher risk in terms of short-term price fluctuations for HELP.Check RPRX's competition here
Corcept Therapeutics Incorporated (NASDAQ: CORT)
HELP vs CORT Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, CORT has a market cap of 12.7B. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while CORT trades at $117.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas CORT's P/E ratio is 336.57. In terms of profitability, HELP's ROE is -0.71%, compared to CORT's ROE of +0.08%. Regarding short-term risk, HELP is more volatile compared to CORT. This indicates higher risk in terms of short-term price fluctuations for HELP.Check CORT's competition here
Walgreens Boots Alliance, Inc. (NASDAQ: WBA)
HELP vs WBA Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, WBA has a market cap of 10.4B. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while WBA trades at $11.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas WBA's P/E ratio is -1.64. In terms of profitability, HELP's ROE is -0.71%, compared to WBA's ROE of -0.57%. Regarding short-term risk, HELP is more volatile compared to WBA. This indicates higher risk in terms of short-term price fluctuations for HELP.Check WBA's competition here
Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA)
HELP vs KNSA Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, KNSA has a market cap of 6B. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while KNSA trades at $78.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas KNSA's P/E ratio is 80.96. In terms of profitability, HELP's ROE is -0.71%, compared to KNSA's ROE of +0.14%. Regarding short-term risk, HELP is more volatile compared to KNSA. This indicates higher risk in terms of short-term price fluctuations for HELP.Check KNSA's competition here
Liquidia Corporation (NASDAQ: LQDA)
HELP vs LQDA Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, LQDA has a market cap of 2.4B. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while LQDA trades at $26.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas LQDA's P/E ratio is 19.57. In terms of profitability, HELP's ROE is -0.71%, compared to LQDA's ROE of +1.50%. Regarding short-term risk, HELP is more volatile compared to LQDA. This indicates higher risk in terms of short-term price fluctuations for HELP.Check LQDA's competition here
Prestige Consumer Healthcare Inc. (NYSE: PBH)
HELP vs PBH Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, PBH has a market cap of 2.3B. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while PBH trades at $48.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas PBH's P/E ratio is 10.98. In terms of profitability, HELP's ROE is -0.71%, compared to PBH's ROE of +0.09%. Regarding short-term risk, HELP is more volatile compared to PBH. This indicates higher risk in terms of short-term price fluctuations for HELP.Check PBH's competition here
Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ: HROWL)
HELP vs HROWL Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, HROWL has a market cap of 1.4B. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while HROWL trades at $25.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas HROWL's P/E ratio is N/A. In terms of profitability, HELP's ROE is -0.71%, compared to HROWL's ROE of -1.04%. Regarding short-term risk, HELP is more volatile compared to HROWL. This indicates higher risk in terms of short-term price fluctuations for HELP.Check HROWL's competition here
Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ: HROWM)
HELP vs HROWM Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, HROWM has a market cap of 1.3B. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while HROWM trades at $26.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas HROWM's P/E ratio is N/A. In terms of profitability, HELP's ROE is -0.71%, compared to HROWM's ROE of -1.04%. Regarding short-term risk, HELP is more volatile compared to HROWM. This indicates higher risk in terms of short-term price fluctuations for HELP.Check HROWM's competition here
Latigo Biotherapeutics Inc. (NASDAQ: LTGO)
HELP vs LTGO Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, LTGO has a market cap of 945M. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while LTGO trades at $15.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas LTGO's P/E ratio is -6.23. In terms of profitability, HELP's ROE is -0.71%, compared to LTGO's ROE of N/A. Regarding short-term risk, HELP is more volatile compared to LTGO. This indicates higher risk in terms of short-term price fluctuations for HELP.Check LTGO's competition here
Sinovac Biotech Ltd. (NASDAQ: SVA)
HELP vs SVA Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, SVA has a market cap of 464.9M. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while SVA trades at $6.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas SVA's P/E ratio is -5.68. In terms of profitability, HELP's ROE is -0.71%, compared to SVA's ROE of -0.01%. Regarding short-term risk, HELP is more volatile compared to SVA. This indicates higher risk in terms of short-term price fluctuations for HELP.Check SVA's competition here
Clinuvel Pharmaceuticals Ltd. (NASDAQ: CUVL)
HELP vs CUVL Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, CUVL has a market cap of 275.6M. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while CUVL trades at $5.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas CUVL's P/E ratio is 11.79. In terms of profitability, HELP's ROE is -0.71%, compared to CUVL's ROE of N/A. Regarding short-term risk, HELP is more volatile compared to CUVL. This indicates higher risk in terms of short-term price fluctuations for HELP.Check CUVL's competition here
Bristol-Myers Squibb Company Ce (NYSE: CELG-RI)
HELP vs CELG-RI Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, CELG-RI has a market cap of 241M. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while CELG-RI trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas CELG-RI's P/E ratio is N/A. In terms of profitability, HELP's ROE is -0.71%, compared to CELG-RI's ROE of +0.47%. Regarding short-term risk, HELP is more volatile compared to CELG-RI. This indicates higher risk in terms of short-term price fluctuations for HELP.Check CELG-RI's competition here
High Tide Inc. (NASDAQ: HITI)
HELP vs HITI Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, HITI has a market cap of 226.7M. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while HITI trades at $2.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas HITI's P/E ratio is -9.53. In terms of profitability, HELP's ROE is -0.71%, compared to HITI's ROE of -0.36%. Regarding short-term risk, HELP is more volatile compared to HITI. This indicates higher risk in terms of short-term price fluctuations for HELP.Check HITI's competition here
Electra Therapeutics Inc. (NASDAQ: ETRA)
HELP vs ETRA Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, ETRA has a market cap of 182.6M. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while ETRA trades at $8.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas ETRA's P/E ratio is -3.25. In terms of profitability, HELP's ROE is -0.71%, compared to ETRA's ROE of N/A. Regarding short-term risk, HELP is less volatile compared to ETRA. This indicates lower risk in terms of short-term price fluctuations for HELP.Check ETRA's competition here
TRex Bio Inc. (NASDAQ: TRXB)
HELP vs TRXB Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, TRXB has a market cap of 113.3M. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while TRXB trades at $13.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas TRXB's P/E ratio is -5.51. In terms of profitability, HELP's ROE is -0.71%, compared to TRXB's ROE of N/A. Regarding short-term risk, HELP is more volatile compared to TRXB. This indicates higher risk in terms of short-term price fluctuations for HELP.Check TRXB's competition here
Citius Oncology, Inc. (NASDAQ: CTOR)
HELP vs CTOR Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, CTOR has a market cap of 71.6M. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while CTOR trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas CTOR's P/E ratio is -1.64. In terms of profitability, HELP's ROE is -0.71%, compared to CTOR's ROE of -1.03%. Regarding short-term risk, HELP is less volatile compared to CTOR. This indicates lower risk in terms of short-term price fluctuations for HELP.Check CTOR's competition here
Atlantic International Corp. (NASDAQ: ATLN)
HELP vs ATLN Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, ATLN has a market cap of 68.6M. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while ATLN trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas ATLN's P/E ratio is -0.68. In terms of profitability, HELP's ROE is -0.71%, compared to ATLN's ROE of -83.20%. Regarding short-term risk, HELP is less volatile compared to ATLN. This indicates lower risk in terms of short-term price fluctuations for HELP.Check ATLN's competition here
Retension Pharmaceuticals Inc. (NASDAQ: RTSN)
HELP vs RTSN Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, RTSN has a market cap of 44.7M. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while RTSN trades at $11.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas RTSN's P/E ratio is -4.57. In terms of profitability, HELP's ROE is -0.71%, compared to RTSN's ROE of N/A. Regarding short-term risk, HELP is more volatile compared to RTSN. This indicates higher risk in terms of short-term price fluctuations for HELP.Check RTSN's competition here
Rite Aid Corporation (NYSE: RAD)
HELP vs RAD Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, RAD has a market cap of 36.8M. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while RAD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas RAD's P/E ratio is -0.05. In terms of profitability, HELP's ROE is -0.71%, compared to RAD's ROE of +2.76%. Regarding short-term risk, HELP is less volatile compared to RAD. This indicates lower risk in terms of short-term price fluctuations for HELP.Check RAD's competition here
Damora Therapeutics, Inc. (NASDAQ: GLTO)
HELP vs GLTO Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, GLTO has a market cap of 34.5M. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while GLTO trades at $21.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas GLTO's P/E ratio is -1.78. In terms of profitability, HELP's ROE is -0.71%, compared to GLTO's ROE of -0.83%. Regarding short-term risk, HELP is more volatile compared to GLTO. This indicates higher risk in terms of short-term price fluctuations for HELP.Check GLTO's competition here
Nasus Pharma Ltd. (AMEX: NSRX)
HELP vs NSRX Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, NSRX has a market cap of 27.8M. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while NSRX trades at $3.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas NSRX's P/E ratio is -4.49. In terms of profitability, HELP's ROE is -0.71%, compared to NSRX's ROE of -1.59%. Regarding short-term risk, HELP is more volatile compared to NSRX. This indicates higher risk in terms of short-term price fluctuations for HELP.Check NSRX's competition here
SCYNEXIS, Inc. (NASDAQ: SCYX)
HELP vs SCYX Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, SCYX has a market cap of 25.1M. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while SCYX trades at $3.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas SCYX's P/E ratio is -1.17. In terms of profitability, HELP's ROE is -0.71%, compared to SCYX's ROE of -0.21%. Regarding short-term risk, HELP is more volatile compared to SCYX. This indicates higher risk in terms of short-term price fluctuations for HELP.Check SCYX's competition here
Cosmos Health Inc. (NASDAQ: COSM)
HELP vs COSM Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, COSM has a market cap of 20.8M. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while COSM trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas COSM's P/E ratio is -0.52. In terms of profitability, HELP's ROE is -0.71%, compared to COSM's ROE of -1.19%. Regarding short-term risk, HELP is less volatile compared to COSM. This indicates lower risk in terms of short-term price fluctuations for HELP.Check COSM's competition here
Cerenome, Inc. (NASDAQ: CNSY)
HELP vs CNSY Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, CNSY has a market cap of 12M. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while CNSY trades at $1.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas CNSY's P/E ratio is -0.41. In terms of profitability, HELP's ROE is -0.71%, compared to CNSY's ROE of -3.94%. Regarding short-term risk, HELP is more volatile compared to CNSY. This indicates higher risk in terms of short-term price fluctuations for HELP.Check CNSY's competition here
Biofrontera Inc. (NASDAQ: BFRI)
HELP vs BFRI Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, BFRI has a market cap of 11.4M. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while BFRI trades at $0.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas BFRI's P/E ratio is -1.62. In terms of profitability, HELP's ROE is -0.71%, compared to BFRI's ROE of -1.28%. Regarding short-term risk, HELP is more volatile compared to BFRI. This indicates higher risk in terms of short-term price fluctuations for HELP.Check BFRI's competition here
China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD)
HELP vs CJJD Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while CJJD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas CJJD's P/E ratio is -0.46. In terms of profitability, HELP's ROE is -0.71%, compared to CJJD's ROE of -0.25%. Regarding short-term risk, HELP is more volatile compared to CJJD. This indicates higher risk in terms of short-term price fluctuations for HELP.Check CJJD's competition here
SunLink Health Systems, Inc. (AMEX: SSY)
HELP vs SSY Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, SSY has a market cap of 7.9M. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while SSY trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas SSY's P/E ratio is -2.86. In terms of profitability, HELP's ROE is -0.71%, compared to SSY's ROE of -0.09%. Regarding short-term risk, HELP is less volatile compared to SSY. This indicates lower risk in terms of short-term price fluctuations for HELP.Check SSY's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
HELP vs SCNX Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, SCNX has a market cap of 5.3M. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while SCNX trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas SCNX's P/E ratio is -1.54. In terms of profitability, HELP's ROE is -0.71%, compared to SCNX's ROE of -0.54%. Regarding short-term risk, HELP is less volatile compared to SCNX. This indicates lower risk in terms of short-term price fluctuations for HELP.Check SCNX's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMS)
HELP vs BGMS Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, BGMS has a market cap of 5.1M. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while BGMS trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas BGMS's P/E ratio is -0.26. In terms of profitability, HELP's ROE is -0.71%, compared to BGMS's ROE of -0.32%. Regarding short-term risk, HELP is more volatile compared to BGMS. This indicates higher risk in terms of short-term price fluctuations for HELP.Check BGMS's competition here
POMDOCTOR Ltd (NASDAQ: POM)
HELP vs POM Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, POM has a market cap of 4.7M. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while POM trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas POM's P/E ratio is -0.12. In terms of profitability, HELP's ROE is -0.71%, compared to POM's ROE of +0.16%. Regarding short-term risk, HELP is less volatile compared to POM. This indicates lower risk in terms of short-term price fluctuations for HELP.Check POM's competition here
Eocene Ltd. (NASDAQ: EOCN)
HELP vs EOCN Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, EOCN has a market cap of 3.3M. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while EOCN trades at $3.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas EOCN's P/E ratio is -0.23. In terms of profitability, HELP's ROE is -0.71%, compared to EOCN's ROE of N/A. Regarding short-term risk, HELP is more volatile compared to EOCN. This indicates higher risk in terms of short-term price fluctuations for HELP.Check EOCN's competition here
Biofrontera Inc. (NASDAQ: BFRIW)
HELP vs BFRIW Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, BFRIW has a market cap of 3.2M. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while BFRIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas BFRIW's P/E ratio is -0.01. In terms of profitability, HELP's ROE is -0.71%, compared to BFRIW's ROE of -1.28%. Regarding short-term risk, HELP is more volatile compared to BFRIW. This indicates higher risk in terms of short-term price fluctuations for HELP.Check BFRIW's competition here
MedAvail Holdings, Inc. (NASDAQ: MDVL)
HELP vs MDVL Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, MDVL has a market cap of 2.9M. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while MDVL trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas MDVL's P/E ratio is -0.05. In terms of profitability, HELP's ROE is -0.71%, compared to MDVL's ROE of -2.39%. Regarding short-term risk, HELP is less volatile compared to MDVL. This indicates lower risk in terms of short-term price fluctuations for HELP.Check MDVL's competition here
Paranovus Entertainment Technology Ltd. (NASDAQ: PAVS)
HELP vs PAVS Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, PAVS has a market cap of 2.9M. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while PAVS trades at $3.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas PAVS's P/E ratio is -0.04. In terms of profitability, HELP's ROE is -0.71%, compared to PAVS's ROE of -0.46%. Regarding short-term risk, HELP is more volatile compared to PAVS. This indicates higher risk in terms of short-term price fluctuations for HELP.Check PAVS's competition here
ETHZilla Corporation Warrant (NASDAQ: ATNFW)
HELP vs ATNFW Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, ATNFW has a market cap of 2.6M. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while ATNFW trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas ATNFW's P/E ratio is N/A. In terms of profitability, HELP's ROE is -0.71%, compared to ATNFW's ROE of -2.15%. Regarding short-term risk, HELP is less volatile compared to ATNFW. This indicates lower risk in terms of short-term price fluctuations for HELP.Check ATNFW's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMSP)
HELP vs BGMSP Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, BGMSP has a market cap of 2.4M. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while BGMSP trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas BGMSP's P/E ratio is -0.84. In terms of profitability, HELP's ROE is -0.71%, compared to BGMSP's ROE of -0.32%. Regarding short-term risk, HELP is more volatile compared to BGMSP. This indicates higher risk in terms of short-term price fluctuations for HELP.Check BGMSP's competition here
AstraZeneca PLC ADRhedged (AMEX: AZNH)
HELP vs AZNH Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, AZNH has a market cap of 1.6M. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while AZNH trades at $53.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas AZNH's P/E ratio is 38.35. In terms of profitability, HELP's ROE is -0.71%, compared to AZNH's ROE of +0.00%. Regarding short-term risk, HELP is more volatile compared to AZNH. This indicates higher risk in terms of short-term price fluctuations for HELP.Check AZNH's competition here
Leafly Holdings, Inc. (NASDAQ: LFLYW)
HELP vs LFLYW Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, LFLYW has a market cap of 299.9K. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while LFLYW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas LFLYW's P/E ratio is -0.00. In terms of profitability, HELP's ROE is -0.71%, compared to LFLYW's ROE of +0.42%. Regarding short-term risk, HELP is more volatile compared to LFLYW. This indicates higher risk in terms of short-term price fluctuations for HELP.Check LFLYW's competition here
ProPhase Labs, Inc. (NASDAQ: PRPH)
HELP vs PRPH Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, PRPH has a market cap of 119.1K. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while PRPH trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas PRPH's P/E ratio is N/A. In terms of profitability, HELP's ROE is -0.71%, compared to PRPH's ROE of -13.59%. Regarding short-term risk, HELP is less volatile compared to PRPH. This indicates lower risk in terms of short-term price fluctuations for HELP.Check PRPH's competition here
Caraco Pharmaceutical Laboratories Ltd (AMEX: CPD)
HELP vs CPD Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, CPD has a market cap of 0. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while CPD trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas CPD's P/E ratio is N/A. In terms of profitability, HELP's ROE is -0.71%, compared to CPD's ROE of N/A. Regarding short-term risk, HELP is more volatile compared to CPD. This indicates higher risk in terms of short-term price fluctuations for HELP.Check CPD's competition here
Orexigen Therapeutics, Inc. (NASDAQ: OREX)
HELP vs OREX Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, OREX has a market cap of 0. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while OREX trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas OREX's P/E ratio is -0.14. In terms of profitability, HELP's ROE is -0.71%, compared to OREX's ROE of -0.54%. Regarding short-term risk, HELP is less volatile compared to OREX. This indicates lower risk in terms of short-term price fluctuations for HELP.Check OREX's competition here
POZEN Inc. (NASDAQ: POZN)
HELP vs POZN Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, POZN has a market cap of 0. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while POZN trades at $5.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas POZN's P/E ratio is N/A. In terms of profitability, HELP's ROE is -0.71%, compared to POZN's ROE of +0.61%. Regarding short-term risk, HELP is less volatile compared to POZN. This indicates lower risk in terms of short-term price fluctuations for HELP.Check POZN's competition here
Impax Laboratories, Inc. (NASDAQ: IPXL)
HELP vs IPXL Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, IPXL has a market cap of 0. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while IPXL trades at $18.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas IPXL's P/E ratio is -10.11. In terms of profitability, HELP's ROE is -0.71%, compared to IPXL's ROE of -1.16%. Regarding short-term risk, HELP is more volatile compared to IPXL. This indicates higher risk in terms of short-term price fluctuations for HELP.Check IPXL's competition here
Shire plc (NASDAQ: SHPG)
HELP vs SHPG Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, SHPG has a market cap of 0. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while SHPG trades at $179.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas SHPG's P/E ratio is 11.35. In terms of profitability, HELP's ROE is -0.71%, compared to SHPG's ROE of +0.13%. Regarding short-term risk, HELP is more volatile compared to SHPG. This indicates higher risk in terms of short-term price fluctuations for HELP.Check SHPG's competition here
Express Scripts Holding Company (NASDAQ: ESRX)
HELP vs ESRX Comparison October 2026
Helus Pharma Inc. (NASDAQ: HELP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HELP stands at 650.8M. In comparison, ESRX has a market cap of 0. Regarding current trading prices, HELP is priced at $10.50 on the NASDAQ, while ESRX trades at $92.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HELP currently has a P/E ratio of -2.52, whereas ESRX's P/E ratio is 10.69. In terms of profitability, HELP's ROE is -0.71%, compared to ESRX's ROE of +0.26%. Regarding short-term risk, HELP is more volatile compared to ESRX. This indicates higher risk in terms of short-term price fluctuations for HELP.Check ESRX's competition here